Carlsmed, the company behind aprevo spine implants, filed for an Initial Public Offering, the company said June 26.
The number of shares and price range are yet to be determined, according to a news release. The offering is subject to market and other conditions.
BofA Securities, Goldman Sachs & Co. LLC and Piper Sandler are the joint lead book-running managers and representatives of the underwriters for the proposed offering. Truist Securities and BTIG are joint book-runners for the proposed offering.
The company filed to raise up to $100 million for the IPO, Renaissance Capital reported. Carlsmed was founded in 2018.
